| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -75.8% |
| R&D Expense | $22.8M | -3.5% |
| SG&A Expense | $5.7M | -18.4% |
| Operating Income | -$27.0M | -8.5% |
| Income Tax | $2K | — |
| Net Income | -$25.0M | -157.3% |
| EPS (Basic) | -$0.81 | +3.6% |
| EPS (Diluted) | -$0.81 | +3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.8M | -52.7% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $23.8M | -51.6% |
| Total Assets | $23.8M | -51.5% |
| Current Liabilities | $3.8M | -43.8% |
| Total Liabilities | $3.8M | -43.8% |
| Stockholders' Equity | $2.0M | -91.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.8M | -11.6% |
| Capital Expenditures | $21K | +200.0% |
| Investing Cash Flow | -$21K | -102.4% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$25.8M | -11.6% |